312 related articles for article (PubMed ID: 30111373)
1. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
[TBL] [Abstract][Full Text] [Related]
2. TNFAIP3 mediates FGFR1 activation-induced breast cancer angiogenesis by promoting VEGFA expression and secretion.
Gao M; Li X; Yang M; Feng W; Lin Y; He T
Clin Transl Oncol; 2022 Dec; 24(12):2453-2465. PubMed ID: 36002765
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer.
Citron F; Segatto I; Vinciguerra GLR; Musco L; Russo F; Mungo G; D'Andrea S; Mattevi MC; Perin T; Schiappacassi M; Massarut S; Marchini C; Amici A; Vecchione A; Baldassarre G; Belletti B
Cancer Res; 2020 Mar; 80(5):1064-1077. PubMed ID: 31862778
[TBL] [Abstract][Full Text] [Related]
5. TNFAIP3 promotes ALDH-positive breast cancer stem cells through FGFR1/MEK/ERK pathway.
Feng W; Gao M; Yang M; Li X; Gan Z; Wu T; Lin Y; He T
Med Oncol; 2022 Sep; 39(12):230. PubMed ID: 36175778
[TBL] [Abstract][Full Text] [Related]
6. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer.
Lee S; Stewart S; Nagtegaal I; Luo J; Wu Y; Colditz G; Medina D; Allred DC
Cancer Res; 2012 Sep; 72(17):4574-86. PubMed ID: 22751464
[TBL] [Abstract][Full Text] [Related]
7. The FGFR1 Signaling Pathway Upregulates the Oncogenic Transcription Factor FOXQ1 to Promote Breast Cancer Cell Growth.
Lin Y; Lin F; Zhang Z; Peng L; Yang W; Yang M; Luo B; Wu T; Li D; Li X; Ran B; Anuchapreeda S; Chaiwongsa R; Khamphikham P; Duangmano S; Xu J; He T; Pornprasert S
Int J Biol Sci; 2023; 19(3):744-759. PubMed ID: 36778115
[TBL] [Abstract][Full Text] [Related]
8.
Abba MC; Canzoneri R; Gurruchaga A; Lee J; Tatineni P; Kil H; Lacunza E; Aldaz CM
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049922
[TBL] [Abstract][Full Text] [Related]
9. Everolimus Inhibits the Progression of Ductal Carcinoma
Chen G; Ding XF; Pressley K; Bouamar H; Wang B; Zheng G; Broome LE; Nazarullah A; Brenner AJ; Kaklamani V; Jatoi I; Sun LZ
Clin Cancer Res; 2020 Mar; 26(6):1486-1496. PubMed ID: 31871301
[TBL] [Abstract][Full Text] [Related]
10. Mouse-INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy.
Hong Y; Limback D; Elsarraj HS; Harper H; Haines H; Hansford H; Ricci M; Kaufman C; Wedlock E; Xu M; Zhang J; May L; Cusick T; Inciardi M; Redick M; Gatewood J; Winblad O; Aripoli A; Huppe A; Balanoff C; Wagner JL; Amin AL; Larson KE; Ricci L; Tawfik O; Razek H; Meierotto RO; Madan R; Godwin AK; Thompson J; Hilsenbeck SG; Futreal A; Thompson A; Hwang ES; Fan F; Behbod F;
J Pathol; 2022 Feb; 256(2):186-201. PubMed ID: 34714554
[TBL] [Abstract][Full Text] [Related]
11. Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast.
Kim M; Choi HY; Woo JW; Chung YR; Park SY
Sci Rep; 2021 Sep; 11(1):18007. PubMed ID: 34504204
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular characterization of two patient-derived ductal carcinoma in situ (DCIS) cell lines, ETCC-006 and ETCC-010.
Samson J; Derlipanska M; Zaheed O; Dean K
BMC Cancer; 2021 Jul; 21(1):790. PubMed ID: 34238275
[TBL] [Abstract][Full Text] [Related]
13. Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness.
Zheng ZY; Elsarraj H; Lei JT; Hong Y; Anurag M; Feng L; Kennedy H; Shen Y; Lo F; Zhao Z; Zhang B; Zhang XH; Tawfik OW; Behbod F; Chang EC
Breast Cancer Res; 2022 Oct; 24(1):68. PubMed ID: 36258226
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma
Shan NL; Minden A; Furmanski P; Bak MJ; Cai L; Wernyj R; Sargsyan D; Cheng D; Wu R; Kuo HD; Li SN; Fang M; Maehr H; Kong AN; Suh N
Cancer Prev Res (Phila); 2020 Aug; 13(8):673-686. PubMed ID: 32467291
[TBL] [Abstract][Full Text] [Related]
15. Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer.
Tan X; Li Z; Ren S; Rezaei K; Pan Q; Goldstein AT; Macri CJ; Cao D; Brem RF; Fu SW
Breast Cancer Res; 2019 Aug; 21(1):89. PubMed ID: 31391072
[TBL] [Abstract][Full Text] [Related]
16. FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer.
Yang Y; Lu T; Li Z; Lu S
Cell Adh Migr; 2020 Dec; 14(1):82-95. PubMed ID: 32380883
[No Abstract] [Full Text] [Related]
17. Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer.
Abdullah A; Akhand SS; Paez JSP; Brown W; Pan L; Libring S; Badamy M; Dykuizen E; Solorio L; Andy Tao W; Wendt MK
Oncogene; 2021 Jan; 40(2):322-333. PubMed ID: 33128042
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA BHLHE40-AS1 promotes early breast cancer progression through modulating IL-6/STAT3 signaling.
DeVaux RS; Ropri AS; Grimm SL; Hall PA; Herrera EO; Chittur SV; Smith WP; Coarfa C; Behbod F; Herschkowitz JI
J Cell Biochem; 2020 Jul; 121(7):3465-3478. PubMed ID: 31907974
[TBL] [Abstract][Full Text] [Related]
19. MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma
Guo Q; Li VZ; Nichol JN; Huang F; Yang W; Preston SEJ; Talat Z; Lefrère H; Yu H; Zhang G; Basik M; Gonçalves C; Zhan Y; Plourde D; Su J; Torres J; Marques M; Habyan SA; Bijian K; Amant F; Witcher M; Behbod F; McCaffrey L; Alaoui-Jamali M; Giannakopoulos NV; Brackstone M; Postovit LM; Del Rincón SV; Miller WH
Cancer Res; 2019 Apr; 79(7):1646-1657. PubMed ID: 30659022
[TBL] [Abstract][Full Text] [Related]
20. Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases.
Acevedo DS; Fang WB; Rao V; Penmetcha V; Leyva H; Acosta G; Cote P; Brodine R; Swerdlow R; Tan L; Lorenzi PL; Cheng N
Neoplasia; 2022 Jun; 28():100791. PubMed ID: 35405500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
